EndoChoice Holdings, which sells gastrointestinal endoscopy systems with wide field-of-view cameras, announced terms for its IPO on Tuesday.
The Alpharetta, GA-based company plans to raise $100 million by offering 6.25 million shares at a price range of $15 to $17. At the midpoint of the proposed range, EndoChoice Holdings would command a fully diluted market value of $396 million.
EndoChoice Holdings, which was founded in 2008 and booked $64 million in sales for the 12 months ended March 31, 2015, plans to list on the NYSE under the symbol GI. J.P. Morgan and BofA Merrill Lynch are the joint bookrunners on the deal. It is expected to price during the week of June 1, 2015.
